Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Leo Pharma patents IL-17 modulators

Jan. 4, 2022

Medshine Discovery discloses EZH2 inhibitors

Jan. 4, 2022

Mission Therapeutics synthesizes USP30 inhibitors

Jan. 3, 2022

Roche presents compounds for Gram-negative bacterial infections

Jan. 3, 2022

Betta Pharmaceuticals divulges new PTPN11 inhibitors

Jan. 3, 2022

Chinese researchers disclose SOS1 inhibitors

Jan. 3, 2022

Medshine Discovery patents new GLP-1 receptor agonists

Jan. 3, 2022

New PD-1/PD-L1 interaction inhibitors identified at Kainos Medicine

Dec. 31, 2021

Kinnate Biopharma discovers FGFR inhibitors

Dec. 31, 2021

CSPC Zhongqi Pharmaceutical Technology patents PTPN11 inhibitors

Dec. 31, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...